SUMMARY Ten-year mortality rates for lung cancer and coronary heart disease have been related to cigarette smoking habits in 17 475 male civil servants aged and in a sample of 8089 male British residents aged 35-69. Both diseases were more frequent in smokers. Lung cancer rates were higher overall for "non-inhalers", particularly in heavy smokers. Tar yield correlated with the risk of lung cancer in non-inhalers but less so in inhalers. Conversely, coronary deaths were more common among inhalers, and the effect of tar/nicotine yield (such as it was) was confined to inhalers. It appears that there are subtle interactions between the amount smoked, the tar/nicotine yield of the cigarette, and the style of smoking. Thus the effects of a change in cigarette characteristics are hard to predict, and they may be different for respiratory and cardiovascular disease.
Cigarette smoking is clearly associated with greatly enhanced risks of dying from coronary heart disease and lung cancer,"s but less is known as to how tobacco smoke either causes or promotes these diseases. It seems likely that lung cancer results from a direct effect of smoke on airways,5 while absorption from smoke of toxic constituents or metabolites contributes to coronary heart disease.6 Fuller understanding is hampered by the chemical complexity of tobacco smoke, whose composition, moreover, undergoes intricate changes during inhalation into the lungs: the site and degree of absorption of each constituent are determined not only by its solubility but also by the manner in which the smoke is inhaled.7 I Little is known of the capacity of the lungs to detoxify tobacco smoke.
Thus the health consequences of smoking depend not only on the amount smoked but also on the composition of the smoke and the manner of smoking. All of these factors interact, so that, for example, a reduction in tar and nicotine yield may sometimes lead to deeper inhalation." This suggests that at present we cannot predict the nett effect of changes in the characteristics of cigarettes.
To gain further insight into the relation of smoking to the development of lung cancer and coronary heart disease we have reviewed the mortality for these diseases among male civil servants in the Whitehall Study,"0 and among men in a sample of the British population surveyed in the US/UK/Norwegian Migrants Study."' A total of 18 403 male civil servants in London, aged 40-64, took (p = 0-03), and thus the highest mortality from lung cancer was seen in non-inhalers who smoked high-tar cigarettes heavily. Table 5 shows the lung cancer results from the migrants study. Among men smoking fewer than 20 cigarettes daily the rates are the same in inhalers and non-inhalers, whereas among heavier smokers they are higher in non-inhalers. This is the same pattern as in the Whitehall Study (last line of table 4).
Mortality from coronary heart disease in the Whitehall Study was higher in inhalers than non-inhalers (relative risk 1-30, p = 0.04); but the In the US/UK/Norwegian Migrants Study the general trend was similar, mortality from coronary heart disease being 1-25 times higher in inhalers than non-inhalers, after adjusting for age and daily cigarettes.
Discussion
In common with previous studies we found among cigarette smokers a much increased risk of lung cancer and fatal coronary heart disease. This risk was dose-related, except perhaps for coronary heart disease in non-inhalers. Our observations point also to a further dimension in the hazards associated with smoking-namely, the manner of smoking seems to relate differently to the risks of lung cancer on the one hand and of coronary heart disease on the other.
A greater risk of coronary heart disease among smokers who inhale is well recognised" 13 It is usually thought that the same should apply to the risk of lung cancer, and the results of Hammond's large American study1 supported this view. In the British doctors study, however, non-inhalers taken as a whole had a higher lung cancer mortality than inhalers.4 This effect arose from a considerable excess among non-inhalers smoking 25 or more cigarettes daily. Our results, from both the Whitehall Study and the US/UK/Norwegian Migrants Study (table 5) , support the reality of this unexpected Cigareues, lung cancer, and coronary heart disease Tim Higenbottam, Martin J Shipley, and Geoffrey Rose phenomenon. There is a consistency between these three studies, and perhaps the different finding in Hammond's study came from a failure to take simultaneous account of the amount smoked.
The occurrence of a risk of lung cancer in smokers who deny inhaling shows that rhe answers to this question are unreliable, since the excess risk must imply exposure of bronchi to smoke. In fact, Wald and his colleagues"4 found that carboxyhaemoglobin levels in self-described non-inhalers were closer to those of inhalers than to those of non-smokers. Habits, moreover, may change, through disease, through a change in the type of cigarette, or for other reasons. The different associations with risk nevertheless show that the question on inhaling serves to discriminate two extremes of smoking behaviour. Other things being equal, the risk of coronary heart disease was higher in those reporting inhalation, whereas the risk of lung cancer was lower, at least for older and heavier smokers. The yield of tar affected the risk of lung cancer more among non-inhalers, whereas an effect of tar (or nicotine) on coronary heart disease was seen mainly among inhalers.
The average tar yield of cigarettes has been falling for many years."5 16 This is due partly to manufacturing changes, partly to a growing preference for filtered cigarettes, and partly to the death of older smokers (who prefer a higher tar yield, (18-23 mg) showed that although cigarette consumption was still a strong risk factor for both lung cancer and coronary heart disease (p <0-01), there were no differences between inhalers and non-inhalers for these causes of death.
The results for coronary heart disease imply that the relationship to smoking depends on the absorption of smoke products. Unfortunately, it is not known which particular factor is to blame. Full inhalation much enhances the alveolar absorption of both soluble and less soluble gaseous components, including nicotine.9
The results for lung cancer are less readily explained. Possibly during full inhalation the smoker passes a concentrated bolus of smoke swiftly past the tumorigenic zone: by the time he exhales, the gases have been largely absorbed and most of the particulate matter has been deposited in the depths of the lungs, whence it is cleared by macrophages or by ciliary action. The situation is different for the non-inhaler-that is, the unwitting inhaler. If his inhalation occurs later in inspiration then the concentration of smoke in the "dead space" air might be higher than for the bolus inhaler: and it is this dead space fraction of the tidal volume that remains longest in contact with the main bronchi. Alternatively, his inhalation may be spread more evenly throughout inspiration with the same effect.
Regardless of the explanation of the phenomenon, the important lesson is that the risks of smoking depend not only on what is smoked but on how it is smoked. The interactions are subtle, incompletely understood, and hence not predictable. Smokers changing to a product yielding less tar and nicotine may tend to compensate for the fall in nicotine by inhaling more deeply.9 This might be additionally beneficial for the lung cancer risk, but it could possibly increase the larger danger of fatal coronary heart disease. More circumspection is needed in advocating such a change, with more research into its long-term influence on the absorption of smoke products. 
